Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: A meta-analysis

International Clinical Psychopharmacology

Volumn 27, Issue 6, 2012, Pages 314-320

  Zhao, Xiaofeng ^a   Huang, Yinglin ^a   Li, Jingying ^a   Ma, Hui ^a   Jin, Qiu ^a   Wang, Yuan ^a   Wu, Lijuan ^a   Zhu, Gang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

5 HT1A receptor; antidepressant; C 1019G; meta analysis

Indexed keywords

SEROTONIN 1A RECEPTOR;

ANTIDEPRESSANT ACTIVITY; DATA EXTRACTION; DNA POLYMORPHISM; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; INFORMATION PROCESSING; MAJOR DEPRESSION; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 84866986550     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32835818bf     Document Type: Review

References (49)

1. Albert PR, Lemonde S (2004). 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 10:575-593. (Pubitemid 39546399)
2. Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, et al. (2007). Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm 114:1065-1068. (Pubitemid 47106451)
3. Arias B, Catalán R, Gastó C, Gutié rrez B, Fañ anás L (2005). Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram. J Psychopharmacol 19:166-172. (Pubitemid 40577221)
4. Artigas F, Adell A, Celada P (2006). Pindolol augmentation of antidepressant response. Curr Drug Targets 7:139-147.
5. Baune BT, Hohoff C, Roehrs T, Deckert J, Arolt V, Domschke K (2008). Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression? Neurosci Lett 436:111-115.
6. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
7. Berney A, Nishikawa M, Benkelfat C, Debonnel G, Gobbi G, Diksic M (2008). An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. Neurochem Int 52:701-708.
8. Bukh JD, Bock C, Vinberg M,Werge T, Gether U, Kessing LV (2010). No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment. Eur Neuropsychopharmacol 20:327-335.
9. Casanovas JM, Hervás I, Artigas F (1999). Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport 10:1441-1445. (Pubitemid 29354326)
10. Czesak M, Lemonde S, Peterson EA, Rogaeva A, Albert PR (2006). Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 26:1864-1871. (Pubitemid 43236999)
11. Dawson LA, Nguyen HQ (2000). The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of ( +-) pindolol. Neuropharmacology 39:1044-1052. (Pubitemid 30155712)
12. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
13. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
14. El Mansari M, Sánchez C, Chouvet G, Renaud B, Haddjeri N (2005). Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30:1269-1277. (Pubitemid 40848081)
15. Gourion D (2008). Antidepressants and their onset of action: a major clinical, methodological and pronostical issue. Encephale 34:73-81.
16. Hajós M, Hajó s-Korcsok E, Sharp T (1999). Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br J Pharmacol 126:1741-1750. (Pubitemid 29213091)
17. Hensler JG (2003). Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 72:1665-1682. (Pubitemid 36136072)
18. Hervás I, Vilaró MT, Romero L, Scorza MC, Mengod G, Artigas F (2001). Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24:11-20.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ 327:557-560. (Pubitemid 37088507)
20. Hong CJ, Chen TJ, Yu YW, Tsai SJ (2006). Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 6:27-33. (Pubitemid 43118308)
21. Illi A, Setä lä-Soikkeli E, Viikki M, Poutanen O, Huhtala H, Mononen N, et al. (2009). 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport 20:1125-1128.
22. Jacobsen KX, Vanderluit JL, Slack RS, Albert PR (2008). HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: essential role in developmental expression. Mol Cell Neurosci 38:349-358.
23. Kato M, Serretti A (2010). Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 15:473-500.
24. Kato M, Fukuda T, Wakeno M, Okugawa G, Takekita Y, Watanabe S, et al. (2009). Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 150B:115-123.
25. Le François B, Czesak M, Steubl D, Albert PR (2008). Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55:977-985.
26. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, et al. (2003). Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788-8799. (Pubitemid 37176660)
27. Lemonde S, Du L, Bakish D, Hrdina P, Albert PR (2004a). Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 7:501-506. (Pubitemid 39648081)
28. Lemonde S, Rogaeva A, Albert PR (2004b). Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. J Neurochem 88:857-868. (Pubitemid 38199306)
29. Lenze EJ, Shardell M, Ferrell RE, Orwig D, Yu-Yahiro J, Hawkes W, et al. (2008). Association of serotonin-1A and 2A receptor promoter polymorphisms with depressive symptoms and functional recovery in elderly persons after hip fracture. J Affect Disord 111:61-66.
30. Levin GM, Bowles TM, Ehret MJ, Langaee T, Tan JY, Johnson JA, et al. (2007). Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness. Mol Diagn Ther 11:155-160. (Pubitemid 46983407)
31. Lifschytz T, Gur E, Lerer B, Newman ME (2004). Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences. J Neurosci Methods 140:133-139. (Pubitemid 39625861)
32. Lima FB, Centeno ML, Costa ME, Reddy AP, Cameron JL, Bethea CL (2009). Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram. Neuroscience 164:676-691.
33. Lin E, Chen PS, Chang HH, Gean PW, Tsai HC, Yang YK, et al. (2009). Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 33:1167-1172.
34. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
35. Noro M, Antonijevic I, Forray C, Kasper S, Kocabas NA, Lecrubier Y, et al. (2010). 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder. Int Clin Psychopharmacol 25:228-231.
36. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ (2006a). Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31:1745-1749. (Pubitemid 44106705)
37. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, et al. (2006b). Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59:106-113. (Pubitemid 43117499)
38. Portella MJ, de Diego-Adeliño J, Puigdemont D, Pé rez-Egea R, Alvarez E, Artigas F, et al. (2009). Pindolol augmentation enhances response outcomes in first depressive episodes. Eur Neuropsychopharmacol 19:516-519.
39. Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, et al. (2011). Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. J Clin Psychiatry 72:962-969.
40. Riad M,Watkins KC, Doucet E, Hamon M, Descarries L (2001). Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci 21:8378-8386. (Pubitemid 33051436)
41. Salanti G, Sanderson S, Higgins JP (2005). Obstacles and opportunities in metaanalysis of genetic association studies. Genet Med 7:13-20. (Pubitemid 40111126)
42. Sawiniec J, Borkowski K, Ginalska G, Lewandowska-Stanek H (2007). Association between 5-hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior. Przegl Lek 64:208-211.
43. Serretti A, Artioli P, Lorenzi C, Pirovano A, Tubazio V, Zanardi R (2004). The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Int J Neuropsychopharmacol 7:453-460. (Pubitemid 39648075)
44. Snoeren EM, Refsgaard LK, Waldinger MD, Olivier B, Oosting RS (2011). Chronic paroxetine treatment does not affect sexual behavior in hormonally sub-primed female rats despite 5-HT1(A) receptor desensitization. J Sex Med 8:976-988.
45. Szewczyk B, Albert PR, Burns AM, Czesak M, Overholser JC, Jurjus GJ, et al. (2009). Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. Int J Neuropsychopharmacol 12:155-168.
46. Woolf B (1955). On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
47. Wu S, Comings DE (1999). A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 9:105-106.
48. Yu YW, Tsai SJ, Liou YJ, Hong CJ, Chen TJ (2006). Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol 16:498-503. (Pubitemid 44376554)
49. Zhao X, Jin Q,Wu L, Huang Y, Li J, Zhu G (2011). Sertraline (Zoloft) response in major depressive disorder is not associated with three 5-HT1A receptor gene polymorphisms (rs6295, rs10042486, or rs1364043) in Chinese-Han patients. Psychiatr Genet [Epub ahead of print].